Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYQVIA in Primary Immunodeficiency Diseases
NCT00814320Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2008
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of Human normal immunoglobulin G in primary immunodeficiency disease (PID), sponsored by Takeda. Started Dec 2008; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT00814320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814320.